| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 6.649 | 13.515 | 10.007 | 17.212 | 27.465 | 37.120 | 39.392 |
| Total Income - EUR | - | - | - | 6.649 | 13.515 | 10.007 | 17.212 | 27.465 | 37.120 | 39.392 |
| Total Expenses - EUR | - | - | - | 3.824 | 6.883 | 13.390 | 12.395 | 16.242 | 24.636 | 27.100 |
| Gross Profit/Loss - EUR | - | - | - | 2.825 | 6.632 | -3.383 | 4.817 | 11.223 | 12.484 | 12.292 |
| Net Profit/Loss - EUR | - | - | - | 2.626 | 6.227 | -3.683 | 4.316 | 10.523 | 10.786 | 10.872 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Operamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 64 | 39.190 | 28.851 | 18.828 | 9.473 | 61 | 1.231 |
| Current Assets | - | - | - | 2.704 | 7.043 | 6.805 | 8.123 | 10.755 | 31.661 | 40.750 |
| Inventories | - | - | - | 118 | 176 | 173 | 169 | 2.267 | 135 | 1.723 |
| Receivables | - | - | - | 613 | 6.735 | 6.607 | 7.848 | 3.317 | 29.433 | 29.141 |
| Cash | - | - | - | 1.972 | 132 | 25 | 105 | 5.171 | 2.092 | 9.885 |
| Shareholders Funds | - | - | - | 2.669 | 8.844 | 4.993 | 9.198 | 19.750 | 30.476 | 41.178 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 99 | 37.389 | 30.663 | 17.752 | 478 | 1.245 | 802 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Operamed S.r.l.